February 2, 2012
AVEO Pharmaceuticals to Present at Several Upcoming Investment Conferences
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Feb. 2, 2012– AVEO Pharmaceuticals, Inc. (Nasdaq: AVEO) today announced that members of the company’s management team are scheduled to present a corporate overview at several upcoming investment conferences. The conference and AVEO presentation details are as follows:
- Leerink Swann 2012 Global Healthcare Conference on Wednesday, February 15, 2012 at 2:30 p.m. (ET) at the Waldorf Astoria Hotel in New York City.
- Citi 2012 Global Healthcare Conference on Monday, February 27, 2012 at 9:00 a.m. (ET) at the Waldorf Astoria Hotel in New York City.
- 2012 RBC Capital Markets’ Global Healthcare Conference on Tuesday, February 28, 2012 at 3:35 p.m. (ET) at the New York Palace Hotel in New York City.
Webcasts of AVEO’s presentations can be accessed by visiting the investors section of the company’s website at investor.aveopharma.com. A replay of the webcasts will be archived on the AVEO website for two weeks following each presentation date, respectively.
AVEO Pharmaceuticals (Nasdaq: AVEO) is a cancer therapeutics company committed to discovering, developing and commercializing targeted therapies to impact patients’ lives. AVEO’s proprietary Human Response Platform™ provides the company unique insights into cancer biology and is being leveraged in the discovery and clinical development of its cancer therapeutics. For more information, please visit the company’s website at www.aveopharma.com.
Source: AVEO Pharmaceuticals, Inc.
AVEO Pharmaceuticals, Inc.
Monique Allaire, 617-299-5810
Pure Communications, Inc.
Caton Lovett, 910-232-7166